Prokai-Tatrai K, Zaman K, Kapic A, Hogan K, Sanchez-Rodriguez G, Silverio A
Int J Mol Sci. 2025; 26(5).
PMID: 40076480
PMC: 11899211.
DOI: 10.3390/ijms26051846.
Kruczkowska W, Galeziewska J, Grabowska K, Gromek P, Czajkowska K, Rybicki M
Molecules. 2025; 30(5).
PMID: 40076240
PMC: 11901451.
DOI: 10.3390/molecules30051017.
Mills A, Corbin D, Dakhallah D, Dakhlallah D, Chantler P, Olfert I
bioRxiv. 2025; .
PMID: 40027767
PMC: 11870428.
DOI: 10.1101/2025.02.13.638202.
Kumar P, Bhaskar K
Front Neurosci. 2025; 19:1561636.
PMID: 40027463
PMC: 11868105.
DOI: 10.3389/fnins.2025.1561636.
Negi N, Ayyannan S, Tripathi R
J Comput Aided Mol Des. 2025; 39(1):10.
PMID: 40021503
DOI: 10.1007/s10822-025-00588-2.
An Update on Neuroaging on Earth and in Spaceflight.
Kuznetsov N, Statsenko Y, Ljubisavljevic M
Int J Mol Sci. 2025; 26(4).
PMID: 40004201
PMC: 11855577.
DOI: 10.3390/ijms26041738.
Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer's Disease and Other Neurological Disorders.
Almutary A, Begum M, Siddiqua A, Gupta S, Chauhan P, Wadhwa K
Mol Neurobiol. 2025; .
PMID: 39956886
DOI: 10.1007/s12035-024-04654-y.
Therapeutic Potential of Arimoclomol Nanomicelles: In Vitro Impact on Alzheimer's and Parkinson's Pathology and Correlation with In Vivo Inflammatory Response.
Xavier-de-Britto I, Gomes-da-Silva N, Gomes Soares M, Follmer C, Dabkiewicz D, Rebelo Alencar L
ACS Chem Neurosci. 2025; 16(4):699-710.
PMID: 39907698
PMC: 11843614.
DOI: 10.1021/acschemneuro.4c00734.
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies.
Mallick R, Basak S, Chowdhury P, Bhowmik P, Das R, Banerjee A
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861166
PMC: 11769149.
DOI: 10.3390/ph18010104.
Calcium Signalling in Neurological Disorders, with Insights from Miniature Fluorescence Microscopy.
Sun D, Amiri M, Meng Q, Unnithan R, French C
Cells. 2025; 14(1.
PMID: 39791705
PMC: 11719922.
DOI: 10.3390/cells14010004.
RNA dysregulation in neurodegenerative diseases.
Li Y, Sun S
EMBO J. 2025; 44(3):613-638.
PMID: 39789319
PMC: 11790913.
DOI: 10.1038/s44318-024-00352-6.
Advancements in diagnosing Post-concussion Syndrome: insights into epidemiology, pathophysiology, neuropathology, neuroimaging, and salivary biomarkers.
Mavroudis I, Petridis F, Ciobica A, Kamal F, Padurariu M, Kazis D
Acta Neurol Belg. 2025; .
PMID: 39776059
DOI: 10.1007/s13760-024-02695-7.
Perspectives of traditional herbal medicines in treating retinitis pigmentosa.
Liu S, Matsuo T, Matsuo C, Abe T, Chen J, Sun C
Front Med (Lausanne). 2024; 11:1468230.
PMID: 39712182
PMC: 11660805.
DOI: 10.3389/fmed.2024.1468230.
Anti-Inflammatory Effects of Honeysuckle Leaf Against Lipopolysaccharide-Induced Neuroinflammation on BV2 Microglia.
Kweon B, Oh J, Lim Y, Noh G, Yu J, Kim D
Nutrients. 2024; 16(22).
PMID: 39599739
PMC: 11597670.
DOI: 10.3390/nu16223954.
Mechanisms and Functions of the Cerebral-Cognitive Reserve in Patients with Alzheimer's Disease: A Narrative Review.
Sidenkova A, Litvinenko V, Bazarny V, Rezaikin A, Zakharov A, Baranskaya L
Consort Psychiatr. 2024; 5(3):17-29.
PMID: 39526013
PMC: 11542915.
DOI: 10.17816/CP15526.
Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials.
Park K, Gao Y
Front Neurosci. 2024; 18:1481390.
PMID: 39513042
PMC: 11541110.
DOI: 10.3389/fnins.2024.1481390.
A Review on the Neuroprotective Effect of .
Worku B, Tolossa N
Oxid Med Cell Longev. 2024; 2024:7694516.
PMID: 39483849
PMC: 11527545.
DOI: 10.1155/2024/7694516.
Cerebrospinal Fluid Neurofilaments Light-Chain Differentiate Patients Affected by Alzheimer's Disease with Different Rate of Progression (RoP): A Preliminary Study.
Blandino V, Colletti T, Ribisi P, Tarantino D, Mosca V, Agnello L
Brain Sci. 2024; 14(10).
PMID: 39451975
PMC: 11505946.
DOI: 10.3390/brainsci14100960.
Repetitive subconcussion results in disrupted neural activity independent of concussion history.
Solar K, Ventresca M, Zamyadi R, Zhang J, Jetly R, Vartanian O
Brain Commun. 2024; 6(5):fcae348.
PMID: 39440300
PMC: 11495223.
DOI: 10.1093/braincomms/fcae348.
GSP1-111 Modulates the Microglial M1/M2 Phenotype by Inhibition of Toll-like Receptor 2: A Potential Therapeutic Strategy for Depression.
Kim R, Mabunga D, Boo K, Kim D, Han S, Shin C
Int J Mol Sci. 2024; 25(19).
PMID: 39408923
PMC: 11476561.
DOI: 10.3390/ijms251910594.